spacer
home > epc > spring 2009 > contingency planning
PUBLICATIONS
European Pharmaceutical Contractor

Contingency Planning

In recent years, many popular prescription drugs, over-thecounter products and medical devices have been forced off the market due to safety concerns. When a regulatory agency decides that a medication presents substantial adverse reactions in the general population, the resulting panic among consumers and the recall process itself can become a challenge to effectively manage. Some companies tend to adopt an ‘it won’t happen to us’ mentality when it comes to product recalls, but the reality is that product recalls can happen to any biopharmaceutical and device company and every second counts in the recall process.

The best strategy is a proactive one. Even if a company thinks it can handle the call volume and other tasks associated with a recall, having a contingency plan in place by researching a capable, experienced outsourcing provider who can step in and provide support is strongly recommended.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer

Sameer Thapar is Director of Global Safety Surveillance and Pharmacovigilance for Omnicare Clinical Research. He is a Doctor of Pharmacy (PharmD) and is licensed pharmacist with over 12 years of pharmaceutical industry experience. His expertise in the pharmacovigilance arena spans the realm of regulatory adherence of Ethics Committees’ and Regulatory Authorities’ guidelines, leading domestic and international Health Authority inspections, to processing, interpreting and submitting clinical (Phase I-IV) safety reports and post-marketing adverse events.

spacer
Sameer Thapar
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

BIO-Europe Spring® 2012 — 6th International Partnering Conference

19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands

BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.  
More info >>

 
News and Press Releases

Norwich Expands Capabilities for Phase I-III Clinical Trials

Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.